Status:
NOT_YET_RECRUITING
Assessment of the Impact of Polycystic Ovary Syndrome on Women's Sexuality
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Polycystic Ovarian Syndrome (PCOS)
Eligibility:
FEMALE
18+ years
Brief Summary
This study, titled SexOPK, aims to evaluate the impact of polycystic ovary syndrome (PCOS) on women's sexual health. PCOS is a common endocrine disorder affecting 5-20% of women of reproductive age, o...
Eligibility Criteria
Inclusion
- For patients in the test group (PCOS):
- Adults
- Carriers of medically diagnosed polycystic ovarian syndrome
- Non-opposition
- For patients in the control group:
- Adults
- Not carriers of polycystic ovarian syndrome
- Unopposed
Exclusion
- Patient under court protection, guardianship, or curatorship
- Does not understand or speak French
Key Trial Info
Start Date :
June 1 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06887296
Start Date
June 1 2026
End Date
June 1 2026
Last Update
May 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Paule de Viguier
Toulouse, France, 31059